RedPoint Oncology
RedPoint Oncology is developing a novel payload class for targeted therapies, such as antibody-drug conjugates, to treat therapy-resistant cancers.
RedPoint Oncology is developing a novel payload class for targeted therapies, such as antibody-drug conjugates, to treat therapy-resistant cancers.